Immunotherapy after surgery helps people with high-risk bladder cancer live cancer-free longer
September 16, 2024
September 16, 2024
WASHINGTON, Sept. 16 -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release:
NIH clinical trial results expand treatment options for this disease
Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder. Researchers found that postsurgic . . .
NIH clinical trial results expand treatment options for this disease
Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder. Researchers found that postsurgic . . .